COMP <GO>
AMN vs PG // ENTERPRISE SCALE & MARKET CAP
AMN Healthcare Services Inc (NYSE) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: AMN 2
— PG 9
▲ ENTERPRISE SCALE & MARKET CAP LEADER: PG
LAST: $47.11 (+0.36%) • MKT CAP: $1.82B
market-cap
$1.82B
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
market-cap
$372.21B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AMN VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AMN | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 28.30% | 51.20% | -22.90 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -7.20% | 25.40% | -32.60 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 16.2x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 12.86% | 3.77% | +9.09 | AMN | /fcf-yield <GO> |
| Operating Margin | -2.00% | 24.30% | -26.30 | PG | /operating-margins <GO> |
| Net Profit Margin | -3.50% | 19.00% | -22.50 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | -8.50% | 0.30% | -8.80 | PG | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.76 | 5.59 | -2.83 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | PG | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 74.8 | 60.3 | +14.50 | AMN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 21.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $1.82B | $372.21B | -$370.39B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AMN REV | PG REV | AMN GROSS % | PG GROSS % | AMN FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.73B | $84.28B | 28.3% | 51.2% | $233.8M | $14.04B |
| FY 2024 | $2.98B | $84.04B | 30.8% | 51.4% | $239.5M | $16.52B |
| FY 2023 | $3.79B | $82.01B | — | — | $372.2M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AMN // BETA —
PG // BETA 0.87